Ketamine Versus Etomidate for Rapid Sequence Intubation
Completed · Phase 4
Conditions studied: Airway Control, Anesthesia, Intubation, Complication
In brief
The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).
Key facts
- Study ID
- NCT01823328
- Run by
- Hennepin Healthcare Research Institute
- People needed
- 143
- Starts
- 2013-09-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2019-05-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age
- Undergoing rapid sequence intubation (RSI) in the Emergency Department
You may not qualify if…
- Known contraindication to ketamine or etomidate
- Patient has a condition in which an increase in heart rate or blood pressure would be hazardous, as judged by the treating physician
- Patient is known or suspected of having increased intracranial pressure, based on the history and physical examination performed by the treating physician.
- Females of child-bearing age, defined as 18-50 years, who do not have a documented pregnancy test in this institution confirming that they are not pregnant or who do not have a confirmed surgical procedure preventing pregnancy, i.e., tubal ligation, hysterectomy. The timing of the pregnancy test at which the investigative team will consider a subject to be non-pregnant is a documented negative test during current hospitalization or upon direct transfer from outside institution during current illness.
- Patient declines participation in the trial by wearing a bracelet marked "KvE declined"
- Prisoner
Where it is running
- Hennepin County Medical Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.